{"id":8315,"date":"2022-08-22T07:39:13","date_gmt":"2022-08-22T05:39:13","guid":{"rendered":"https:\/\/www.aieop.org\/web\/?p=8315"},"modified":"2022-08-23T13:35:30","modified_gmt":"2022-08-23T11:35:30","slug":"meet-aieops-board-of-directors-4","status":"publish","type":"post","link":"https:\/\/www.aieop.org\/web\/meet-aieops-board-of-directors-4\/","title":{"rendered":"Meet AIEOP\u2019s Board of Directors"},"content":{"rendered":"

Meet AIEOP’s Board of Directors<\/h2><\/span>
<\/div><\/div><\/div>

Each week we will be featuring one of AIEOP\u2019s board members as an opportunity to know their work as leaders of the association and as individuals part of the international pediatric oncology medical community!<\/p>\n

MEET Dr. Elisa Tirtei<\/p>\n

\"\"<\/p>\n

City:\u00a0<\/strong>Turin
\nInstitution:\u00a0<\/strong>Regina Margherita\u00a0Children\u2019s\u00a0Hospital,\u00a0Turin\u00a0University, AOU Citt\u00e0 Della Salute e della Scienza
\nPosition:\u00a0<\/strong>Medical Doctor, Pediatric Onco-Hematology Department<\/p>\n

What is your academic and\/or professional background (degree and specialty)?<\/strong>
\nAfter graduating with a degree in Medicine and Surgery from the University of Bologna, I moved to Turin where I attended the\u00a0Scuola di Specialit\u00e0 di Oncologia Medica. During my training, I immediately dedicated myself to Pediatric Oncology with a specific focus on the management of early phase clinical trials (phase 1-2), which is why I also carried out a fellowship in Paris.<\/em><\/p>\n

What is your focus or particular interests in your field?<\/strong>
\nMy work is particularly focused on children and adolescents diagnosed with osteosarcoma and patients being treated with new drugs in phase 1 and 2 clinical trials. In addition, \u00a0I am part of the team that coordinates the genomic sequencing analysis of a national AIEOP study for bone sarcomas.<\/em><\/p>\n

What are your specific tasks and responsibilities with the Board Directors?<\/strong>
\nMy main role is first and foremost to participate in the decisions that we as the board of directors must make regarding the overall responsibilities of the association, bringing my own individual contributions to these decisions.<\/em>
\nSpecifically, I am involved with the annual AIEOP Days and the National Congress, and I represent a connection point between our scientific society and other European organizations and groups in which I actively participate.<\/em><\/p>\n

What is your goal or hope for AIEOP?<\/strong>
\nI hope that AIEOP can grow as a scientific society by reaching more and more Italian professionals from different specialties for the highest level of multidisciplinary treatment and care for our patients.<\/em>
\nAIEOP must continue in its role of widespread communication and connectivity between all the centers in order to be able to offer adequate and quality care to all Italian children.<\/em>
\nIn this moment of important\u00a0scientific changes in the diagnosis and treatment of pediatric oncological diseases, it is increasingly necessary to \u201cnetwork\u201d to provide even better patient care.\u00a0Having a 360\u00b0 network means the opportunity for sharing and building diagnosis and treatment protocols, guidelines and training projects for young specialists.\u00a0<\/em><\/p>\n

What is your life motto or quote in which you live by a professional and individual?<\/strong>
\nHonestly, I don\u2019t have a one single life motto, but I believe these words reflect my beliefs:\u00a0<\/em>
\n\u201cI always thought that the first charity the patient should receive from the doctor is the charity of science. It is the charity to be cured as the patient should\u2026\u201d (Dr. Giancarlo Rastelli, Mayo Clinic)<\/em>
\nAnd:\u00a0\u201cThe only way to do great work is to love what you do.\u00a0Going to bed at night saying we\u2019ve done something wonderful, that\u2019s what matters to me.\u201d (Steve Jobs, Apple)<\/em><\/p>\n

\u00a0<\/em><\/p>\n

*** The AIEOP Board of Directors has the responsibility to achieve the statutory objectives and verify that the association\u2019s activities are carried out in compliance with the provisions of the statute and regulations. It is their duty to promote and encourage all initiatives aimed at increasing and enhancing the humanisation of care for the hemato-oncological children and their families.<\/p>\n<\/div>

<\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18],"tags":[],"class_list":["post-8315","post","type-post","status-publish","format-standard","hentry","category-in-evidenza"],"_links":{"self":[{"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/posts\/8315","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/comments?post=8315"}],"version-history":[{"count":6,"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/posts\/8315\/revisions"}],"predecessor-version":[{"id":8324,"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/posts\/8315\/revisions\/8324"}],"wp:attachment":[{"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/media?parent=8315"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/categories?post=8315"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/tags?post=8315"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}